Joel S. Marcus - Sep 14, 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
Director
Signature
/s/ Shoshana Shendelman, as attorney-in-fact
Stock symbol
APLT
Transactions as of
Sep 14, 2022
Transactions value $
$40,156
Form type
4
Date filed
9/16/2022, 09:01 PM
Previous filing
Aug 19, 2022
Next filing
Nov 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Options Exercise $7.76K +7.39K +1.93% $1.05 390K Sep 14, 2022 Direct F1
transaction APLT Common Stock Options Exercise $10.7K +10.2K +2.62% $1.05 400K Sep 14, 2022 Direct
transaction APLT Common Stock Options Exercise $17.3K +16.5K +4.12% $1.05 417K Sep 14, 2022 Direct
transaction APLT Common Stock Options Exercise $4.33K +4.13K +0.99% $1.05 421K Sep 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLT Employee Stock Option (Right to Buy) Options Exercise $0 -7.39K -100% $0.00* 0 Sep 14, 2022 Common Stock 7.39K $1.05 Direct F2
transaction APLT Employee Stock Option (Right to Buy) Options Exercise $0 -10.2K -100% $0.00* 0 Sep 14, 2022 Common Stock 10.2K $1.05 Direct F2
transaction APLT Employee Stock Option (Right to Buy) Options Exercise $0 -16.5K -100% $0.00* 0 Sep 14, 2022 Common Stock 16.5K $1.05 Direct F2
transaction APLT Employee Stock Option (Right to Buy) Options Exercise $0 -4.13K -25% $0.00 12.4K Sep 14, 2022 Common Stock 4.13K $1.05 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 67,435 shares previously reported as indirectly held through a family trust of which the reporting person and his spouse are trustees. In accordance with SEC guidance with respect to shares held by living trusts, such shares are now included in the shares directly owned by the reporting person.
F2 These Options are fully vested.
F3 Reflects an initial grant of 16,500 Options granted on June 3, 2022 to directors under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date.